“The search for a Covid-19 cure and an end to global shutdowns has created a new type of investor in health-care stocks: the biotech tourist,” observes the author of today’s article. As one market watcher explains, these investors are “generalists who are ‘throwing money at headlines’ about any Covid-19-tied companies that are generating ‘pockets of froth’” – and this activity is having a significant impact on valuations and short-selling. For more, CLICK HERE.